Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Condition(s):Dry Age-related Macular DegenerationLast Updated:April 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Dry Age-related Macular DegenerationLast Updated:April 2, 2021Completed
Condition(s):Age-Related Macular DegenerationLast Updated:July 13, 2021Completed
Condition(s):Wet Age-related Macular DegenerationLast Updated:February 28, 2017Terminated
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:April 27, 2021Completed
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 29, 2020Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 31, 2016Withdrawn
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:October 4, 2022Completed
Condition(s):Age-Related MaculopathyLast Updated:March 16, 2016Terminated
Condition(s):Neovascular Age-related Macular Degeneration (NVAMD); Diabetic Macular Edema (DME)Last Updated:December 7, 2023Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:March 26, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.